Deepak Assudani

1.4k citations
29 papers · 1.1k · 2 hit papers · h-index 13

Impact in

  • Immunology top 5%
    • Immunotherapy and Immune Responses
    • Psoriasis: Treatment and Pathogenesis
    • Immune Cell Function and Interaction
    • Biosimilars and Bioanalytical Methods
    • Spondyloarthritis Studies and Treatments
    • Rheumatoid Arthritis Research and Therapies

Papers in

    • Immunodeficiency and Autoimmune Disorders 5
    • Psoriasis: Treatment and Pathogenesis 5
    • Immunotherapy and Immune Responses 4
    • Biosimilars and Bioanalytical Methods 4
    • Immune Cell Function and Interaction 4
    • T-cell and B-cell Immunology 3
    • Spondyloarthritis Studies and Treatments 9

Deepak Assudani

28 papers receiving 1.1k citations

Deepak Assudani's Hit Papers

Bimekizumab in patients with active psoriatic arthritis and previous inadequate response or intolerance to tumour necrosis factor-α inhibitors: a randomised, double-blind, placebo-controlled, phase 3 trial (BE COMPLETE) 2022 · 111 citations
1110+1+2Years since publication255075100

Peers

Deepak Assudani
Comparison fields: 5 of 70
  • Immunology 668
  • Rheumatology 276
  • Oncology 287
  • Hematology 86
  • Dermatology 58
Replace Keiko Hodohara with:
Keiko Hodohara Japan
Martin Birkhofer United States
Sandra J. Meech United States
Steven Y. Hua United States
Luis Marı́n Spain
Mitsuo Okubo Japan
M. Bunce United Kingdom
Andrew R. Rezvani United States
Valérie Coiteux France
Atsushi Wakita Japan
Deepak Assudani relative to Keiko Hodohara Japan Keiko Hodohara's profile →
Citations per field
00.5×7.9×
Keiko Hodohara · 1×
Citations per year

Countries citing papers authored by Deepak Assudani

Since Specialization
Citations

This map shows the geographic impact of Deepak Assudani's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Deepak Assudani with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Deepak Assudani more than expected).

Fields of papers citing papers by Deepak Assudani

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Deepak Assudani. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Deepak Assudani. The network helps show where Deepak Assudani may publish in the future.

Co-authors

The 25 scholars most cited alongside Deepak Assudani, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Deepak Assudani Line = papers co-authored together Deepak Assudani links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 29 papers — load more, or switch the sort, to bring in the rest.

#Work
1 2010383
2
Bimekizumab in patients with active psoriatic arthritis and previous inadequate response or intolerance to tumour necrosis factor-α inhibitors: a randomised, double-blind, placebo-controlled, phase 3 trial (BE COMPLETE)
Hit paper breakdown →
2022111
3 2020110
4
Bimekizumab in patients with psoriatic arthritis, naive to biologic treatment: a randomised, double-blind, placebo-controlled, phase 3 trial (BE OPTIMAL)
Hit paper breakdown →
2022104
5 201899
6 201650
7 200844
8 200631
9 202230
10 201014
11 200513
12 201612
13 202212
14 200811
15 201810
16 20158
17 20157
18 20147
19 20226
20 20196

About Deepak Assudani

Deepak Assudani is a scholar working on Immunology, Rheumatology, Microbiology, Epidemiology and Oncology, having authored 29 papers that have together received 1.1k indexed citations. Recurring topics across this work include Spondyloarthritis Studies and Treatments (9 papers), Immunodeficiency and Autoimmune Disorders (5 papers), Psoriasis: Treatment and Pathogenesis (5 papers), Bacterial Infections and Vaccines (5 papers), Immunotherapy and Immune Responses (4 papers), Biosimilars and Bioanalytical Methods (4 papers), Immune Cell Function and Interaction (4 papers) and T-cell and B-cell Immunology (3 papers). The work is most often cited by research in Immunology (668 citations), Rheumatology (276 citations), Oncology (287 citations), Hematology (86 citations) and Dermatology (58 citations). Deepak Assudani has collaborated with scholars based in United States, United Kingdom and Germany. Frequent co-authors include Hyun-Il Cho, Esteban Celis, Terri Hunter, Scott Antonia, Dmitry I. Gabrilovich, Rupal Ramakrishnan, Srinivas Nagaraj, Soner Altiok, Barbara Ink and Jason Coarse. Their work appears in journals such as Annals of the Rheumatic Diseases, Human Vaccines & Immunotherapeutics, The Lancet, Cancer Immunology Immunotherapy and Arthritis Care & Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact